1.Postnatal Body Weight Changes in Preterm SGA and Preterm AGA Infants on Fluid Restriction Therapy.
Shin Won YOON ; Ran NAMGUNG ; Chul LEE
Korean Journal of Perinatology 2002;13(4):420-426
OBJECTIVE: To determine the differences in water balance between preterm small for gestational age (SGA) and appropriate for gestational age(AGA) infants, we compared the difference in initial physiologic weight loss during the first five days of life and studied associated factors influencing the initial physiologic weight loss in preterm SGA and AGA infants. METHODS: We retrospectively analyzed water and electrolyte balance in 51 preterm low birth weight infants of whom 20 were preterm SGA infants(gestational age, 30.4+/-1.6weeks:birth weight, 970+/-180g) and 31 preterm AGA infants(30+/-1.7 weeks:1437+/-276g) matched by gestation. RESULTS: The percent weight loss was significantly lower in SGA than in AGA infants(p=0.01). The percent weight loss on the fifth day of life were 12.1+/-5.3% in SGA and 15.8+/-4.3% in AGA infants, respectively(p=<0.01). SGA infants had significantly lower urine output on the second and third day of life compared to AGA infants. Diuresis started on the second day of life in AGA infants and on the fifth day of life in SGA infants. CONCLUSION: The initial physiologic weight loss in SGA infants occurred in a smaller degree compared with AGA infants. This was associated with lower urine volume and the delay in onset of diuresis in SGA infants. These differences in water balance in SGA and AGA infants should be considered in the management of preterm low birth weight infants on mechanical ventilation.
Body Weight Changes*
;
Body Weight*
;
Diuresis
;
Gestational Age
;
Humans
;
Infant*
;
Infant, Low Birth Weight
;
Infant, Newborn
;
Pregnancy
;
Respiration, Artificial
;
Retrospective Studies
;
Water-Electrolyte Balance
;
Weight Loss
2.Chondroid Chordoma in the Cavernous Sinus: Case Report.
Won Chul NAMGUNG ; Hyung Shik SHIN ; Young Soon HWANG ; Sang Keun PARK
Journal of Korean Neurosurgical Society 2003;33(1):91-93
The authers report a case of chondroid chordoma in the cavernous sinus. The chondroid chordoma is an uncommon variant of typical chordoma(0.2% of intracranial tumors) and reported usual locations of the chondroid chordoma are clival, parasellar, intrasellar, temporal region, other skull base and extracranial areas. Reported cases of this tumor arising in the cavernous sinus is very rare. We report a case of cavernous sinus chondroid chordoma presenting with clinical symptoms by hemorrhage.
Cavernous Sinus*
;
Chordoma*
;
Hemorrhage
;
Skull Base
3.Risk factors for Pulmonary Interstitial Emphysema (PIE) in Mechanically Ventilated Neonates with Hyaline Membrane Disease.
Shin Won YOON ; Chul LEE ; Jeong Nyun KIM ; Ran NAMGUNG ; Dong Gwan HAN ; Myung Joon KIM
Journal of the Korean Pediatric Society 1997;40(3):318-326
PURPOSE: Pulmonary interstitial emphysema (PIE) is a common and serious complication of mechanical ventilation in infants with hyaline membrane disease. This abnormal collection of gases has two basic roentgenographic features; linear and cyst-like radiolucencies. High positive inspiratory pressure was found to be the most significant parameter associated with development of fatal pulmonary interstitial emphysema. Without prompt conservative management such as lowering peak inspiratory pressure, PIE often progress to a pneumothorax with increased mortality. We studied the incidence and risk factors of PIE and associated risk factors which progress to pneumothorax in mechanically ventilated infants with hyaline membrane disease. METHODS: We reviewed retrospectively the charts of infants who had been admitted to the neonatal intensive care unit between Jan. 1990 and Mar. 1995. A hundred and two infants who were diagnosed as hyaline membrane disease and mechanically ventilated were included in the study. Analysis of clinical characteristics and ventilator parameters were made. Chest radiographs were reviewed for hyaline membrane disease, PIE, pneumothorax by a pediatric radiologist without knowledge of their clinical course. RESULTS: 1) We observed PIE in 14 of 102 infants (13.7%) of which 11 infants progressed to develop pneumothorax. 2) Low gestational age, low apgar score and high peak inspiratory pressure were the factors significantly associated with development of PIE. 3) PIE was frequently located bilaterally (52%), distributed on whole lung parenchyme (92%). Sizes of radiolucency were variable including blebs. 4) Early onset PIE and failure to promptly lower peak inspiratory pressure were the associated risk factors for development of pneumothorax. 5) Pneumothorax developed within a mean 7.5 hours after apperance of PIE. Right side pneumothorax was more frequent (67%). Mortality increased to 73% with development of pneumothorax in PIE. CONCLUSIONS: Early diagnosis of PIE and prompt lowering of peak inspiratory pressure should be emphasized to improve the survival and outcome of mechanically ventilated hyaline membrane diasease infants.
Apgar Score
;
Blister
;
Early Diagnosis
;
Emphysema*
;
Gases
;
Gestational Age
;
Humans
;
Hyalin*
;
Hyaline Membrane Disease*
;
Incidence
;
Infant
;
Infant, Newborn*
;
Intensive Care, Neonatal
;
Lung
;
Membranes
;
Mortality
;
Pneumothorax
;
Radiography, Thoracic
;
Respiration, Artificial
;
Retrospective Studies
;
Risk Factors*
;
Ventilators, Mechanical
4.Urokinase Treatment for Aortic Thrombus in Preterm Infants.
Kyung Won KIM ; Dong Woo LEE ; Ran NAMGUNG ; Min Soo PARK ; Chul LEE ; Myeong Jun KIM
Journal of the Korean Society of Neonatology 2004;11(2):203-209
PURPOSE: Aortic thrombus is a rare but serious complication in neonates, usually associated with central vessel catheterization. Currently treatment of asymptomatic aortic thrombus in preterm infants is controversial. We evaluated effects of urokinase in preterm infants with aortic thrombi. METHODS: We studied 12 preterm infants in whom umbilical arterial catheterizations were performed and subsequently aortic thrombi were detected. In six patients bolus doses of urokinase 4, 400 IU/kg were injected, followed by continuous infusions of 4, 400 IU/kg/hr. The mean duration of urokinase use was 11 days (6-13 days). The other six patients who did not receive urokinase served as controls. The two groups were compared for changes in the size of thrombi. RESULTS: The initial sizes of aortic thrombi upon detection were similar, although the diagnoses were made earlier in urokinase group than in controls. The days to 50% reduction in size of thrombi were significantly shorter in urokinase group, as were the days to complete resolution. One infant in urokinase group and 2 infants in control group had persistent aortic thrombi up to 90 days of follow-up. Intracranial hemorrhage and disseminated intravascular coagulopathy were absent in all 12 cases. CONCLUSION: Urokinase administration could be an effective therapy for preterm neonates with aortic thrombi. It significantly reduces the size of the thrombus and shortens the days to complete resolution.
Catheterization
;
Catheters
;
Diagnosis
;
Follow-Up Studies
;
Humans
;
Infant
;
Infant, Newborn
;
Infant, Premature*
;
Intracranial Hemorrhages
;
Thrombosis*
;
Urokinase-Type Plasminogen Activator*
5.A case of neonatal herpes simplex virus encephalitis.
Kook In PARK ; Young Mo SOHN ; Dong Soo KIM ; Ran NAMGUNG ; Chul LEE ; Dong Gwan HAN ; Won Young LEE ; Ki Keun OH ; Myung Joon KIM
Journal of the Korean Pediatric Society 1991;34(9):1276-1285
No abstract available.
Herpes Simplex*
;
Simplexvirus*
6.Current status of postoperative morbidity following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer with peritoneal metastasis: a prospective single-center observational study
Jae Won JO ; Jung Wook SUH ; Sung Chul LEE ; Hwan NAMGUNG ; Dong-Guk PARK
Annals of Surgical Treatment and Research 2025;108(1):12-19
Purpose:
This study aimed to evaluate current morbidity rates following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colorectal cancer and peritoneal metastasis.
Methods:
A total of 42 patients who underwent CRS and HIPEC for colorectal cancer with peritoneal metastasis at a single tertiary referral center between January 2022 and December 2022 were included. Perioperative outcomes and postoperative complications were prospectively assessed.
Results:
The mean peritoneal cancer index (PCI) was 16.0. The distribution of PCI scores was as follows: <10, 33.3%; 10– 19, 26.2%; and ≥ 20, 40.5%. Completeness of the cytoreduction (CCR) scores were as follows: 57.1% of patients achieved CCR-0, 16.7% achieved CCR-1, 7.1% achieved CCR-2, and 19.0% achieved CCR-3. The mean operation time was 9.1 hours, and the median hospital stay was 17.0 days. Postoperative complications occurred within 30 days in 47.6% of cases and between 30 and 60 days in 11.9% of cases. Reoperation within 30 days was required in 5 cases, and 1 patient died within 30 days. The most common complications were pleural effusion (5 patients), anastomosis site leakage (3 patients), and pneumonia (3 patients). Patients with higher PCI scores were more likely to experience complications (P = 0.038).
Conclusion
Although CRS and HIPEC are still associated with high morbidity and mortality compared to other colorectal surgeries, outcomes have improved with increased experience. These results suggest that the procedure is becoming a more acceptable treatment option over time.
7.Current status of postoperative morbidity following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer with peritoneal metastasis: a prospective single-center observational study
Jae Won JO ; Jung Wook SUH ; Sung Chul LEE ; Hwan NAMGUNG ; Dong-Guk PARK
Annals of Surgical Treatment and Research 2025;108(1):12-19
Purpose:
This study aimed to evaluate current morbidity rates following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colorectal cancer and peritoneal metastasis.
Methods:
A total of 42 patients who underwent CRS and HIPEC for colorectal cancer with peritoneal metastasis at a single tertiary referral center between January 2022 and December 2022 were included. Perioperative outcomes and postoperative complications were prospectively assessed.
Results:
The mean peritoneal cancer index (PCI) was 16.0. The distribution of PCI scores was as follows: <10, 33.3%; 10– 19, 26.2%; and ≥ 20, 40.5%. Completeness of the cytoreduction (CCR) scores were as follows: 57.1% of patients achieved CCR-0, 16.7% achieved CCR-1, 7.1% achieved CCR-2, and 19.0% achieved CCR-3. The mean operation time was 9.1 hours, and the median hospital stay was 17.0 days. Postoperative complications occurred within 30 days in 47.6% of cases and between 30 and 60 days in 11.9% of cases. Reoperation within 30 days was required in 5 cases, and 1 patient died within 30 days. The most common complications were pleural effusion (5 patients), anastomosis site leakage (3 patients), and pneumonia (3 patients). Patients with higher PCI scores were more likely to experience complications (P = 0.038).
Conclusion
Although CRS and HIPEC are still associated with high morbidity and mortality compared to other colorectal surgeries, outcomes have improved with increased experience. These results suggest that the procedure is becoming a more acceptable treatment option over time.
8.Current status of postoperative morbidity following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer with peritoneal metastasis: a prospective single-center observational study
Jae Won JO ; Jung Wook SUH ; Sung Chul LEE ; Hwan NAMGUNG ; Dong-Guk PARK
Annals of Surgical Treatment and Research 2025;108(1):12-19
Purpose:
This study aimed to evaluate current morbidity rates following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colorectal cancer and peritoneal metastasis.
Methods:
A total of 42 patients who underwent CRS and HIPEC for colorectal cancer with peritoneal metastasis at a single tertiary referral center between January 2022 and December 2022 were included. Perioperative outcomes and postoperative complications were prospectively assessed.
Results:
The mean peritoneal cancer index (PCI) was 16.0. The distribution of PCI scores was as follows: <10, 33.3%; 10– 19, 26.2%; and ≥ 20, 40.5%. Completeness of the cytoreduction (CCR) scores were as follows: 57.1% of patients achieved CCR-0, 16.7% achieved CCR-1, 7.1% achieved CCR-2, and 19.0% achieved CCR-3. The mean operation time was 9.1 hours, and the median hospital stay was 17.0 days. Postoperative complications occurred within 30 days in 47.6% of cases and between 30 and 60 days in 11.9% of cases. Reoperation within 30 days was required in 5 cases, and 1 patient died within 30 days. The most common complications were pleural effusion (5 patients), anastomosis site leakage (3 patients), and pneumonia (3 patients). Patients with higher PCI scores were more likely to experience complications (P = 0.038).
Conclusion
Although CRS and HIPEC are still associated with high morbidity and mortality compared to other colorectal surgeries, outcomes have improved with increased experience. These results suggest that the procedure is becoming a more acceptable treatment option over time.
9.A case of Prune Belly syndrome.
Young Sook KIM ; Byung Sik CHANG ; Hye Jung JOO ; Kook In PARK ; Ran NAMGUNG ; Chul LEE ; Dong Gwan HAN ; Yong Won PARK ; Jae Sung CHO ; Eun Chan BAIK ; Chan Ho SONG
Korean Journal of Perinatology 1992;3(2):84-92
No abstract available.
Prune Belly Syndrome*
10.Physical and Biological Activity of Domestic Product of Modified Bovine Lung Surfactant.
Chul LEE ; Min Soo PARK ; Moon Sung PARK ; Jung Nyeon KIM ; Jong Wook LEE ; Kwang Hyun YOU ; Won Jae KWAG ; Kook In PARK ; Ran NAMGUNG ; Dong Gwan HAN
Journal of the Korean Pediatric Society 1997;40(6):771-785
PURPOSE: Neonatal respiratory distress syndrome is caused by the deficiency of lung surfactant in premature babies. For the treatment of RDS at present surfactants such as Surfacten (Tokyo-Tanabe Co., Japan) and Exosurf (Wellcome Co., USA) are used. As awarded the grant from the Ministry of Science and Technology for a model research project of Medium-Technology program, we have modified (supplemented) the bovine lung extracts to get YY-38, for which we have performed physical and biological activities. METHODS: For physical properties, we performed stable microbubble test (SMR) and measured surface tension lowering activity using a pulsating bubble surfactometer. Minimum and maximum surface tensions measured at 1 and 5 minutes gave surface tension-surface area diagrams, from which compressibility at surface tension 10mN/m was also calculated. As to the biological activity, we used premature rabbit fetuses as a model for the study of pressure-lung volume relationship. The lung pathology was examined on the lung tissues subsequently obtained, and aerated area ratios were calculated based on the area measured by an image analyzer. RESULTS: The minimum surface tensions of YY-38 at 1 and 5 minutes for all different concentrations were low at 10mN/m, while the maximum surface tensions ranged from 33.01mN/m to 41.07mN/m. The surface tension-surface area curve showed a definite hysteresis at 1 and 5 minutes for all concentrations, and the surface tension fell below 10mN/m with 20% surface area compression. The compressibilities at surface tension 10mN/m at 5minutes for all concentrations were all below 0.02. In animal experiments, the mean lung volume of premature rabbit fetuses was inflated to 80.9ml/kg at maximum 30cmH2O, while the lung volume was maintained at 38.3mg/kg when the lung was deflated to 5cmH2O. The overall aerated area ratio was 45.4%. CONCLUSIONS: YY-38 formed sufficient amount of stable microbubbles and had a surface tension low enough to maintain alveolar stability and to exhibit a good hysteresis curve. In animal experiments it helped the expansion of premature lungs during inspiratory phase and was effective in the prevention of collapse during expiratory phase.
Animal Experimentation
;
Awards and Prizes
;
Fetus
;
Financing, Organized
;
Lung*
;
Microbubbles
;
Pathology
;
Respiratory Distress Syndrome, Newborn
;
Surface Tension
;
Surface-Active Agents